Pet Health
Pathogenesis of Congestive Heart Failure in Cats
Feline congestive heart failure (CHF) is not a single disease or a diagnosis that identifies one specific cause.
Key takeaways
Congestive heart failure in cats develops when underlying heart disease impairs cardiac function, raises pressure within the heart and circulation, and causes fluid to accumulate in or around the lungs.
- Feline congestive heart failure (CHF) is not a single disease or a diagnosis that identifies one specific cause.
- It is a clinical syndrome that develops when structural or functional abnormalities of the heart interfere with normal circulation.
- Understanding its pathogenesis means following the changes from the original heart muscle disease to impaired filling, increased cardiac pressure, fluid accumulation, and respiratory distress.
- The most important underlying disease is cardiomyopathy, particularly hypertrophic cardiomyopathy (HCM).
- However, restrictive, dilated, arrhythmogenic, and other myocardial disorders can also lead to heart failure.
- Some cats have significant heart disease without developing clinical CHF, while others progress to heart failure, arterial thromboembolism, or sudden death.
1. What heart diseases cause congestive heart failure in cats?
The most common underlying cardiac condition is hypertrophic cardiomyopathy.
However, several different abnormalities can interfere with the heart's ability to fill with or pump blood.
The main cardiomyopathy phenotypes are:
• Hypertrophic cardiomyopathy (HCM): The muscular wall of the left ventricle becomes abnormally thick. The ventricular chamber may become smaller, and the thickened muscle has difficulty relaxing and filling with blood.
• Restrictive cardiomyopathy (RCM): Scarring and stiffness of the heart muscle or its inner lining restrict ventricular filling. Enlargement of the atria is common.
• Dilated cardiomyopathy (DCM): The left ventricle becomes enlarged and loses its ability to contract effectively. This reduces the amount of blood pumped into circulation.
• Arrhythmogenic cardiomyopathy: Structural abnormalities, particularly involving the right ventricle, are associated with abnormal heart rhythms and can lead to right-sided heart failure.
• Nonspecific cardiomyopathy: Some myocardial disorders do not fit neatly into the established categories.
Secondary causes and contributing conditions
Not every abnormality in the heart muscle represents primary inherited cardiomyopathy. Some conditions can produce similar structural and functional changes.
Important conditions include:
• Systemic hypertension, which increases the pressure against which the heart must pump.
• Hyperthyroidism, which increases cardiovascular workload and can cause cardiac remodeling.
• Myocardial inflammation, which can damage heart muscle.
• Growth hormone excess, which is a less common cause of cardiac abnormalities.
• Taurine deficiency, which can cause impaired myocardial contraction and dilated cardiomyopathy.
• Congenital cardiac abnormalities, including defects that create abnormal blood flow between chambers or vessels.
The distinction matters because identifying an underlying, potentially treatable condition can change the diagnostic approach and management.
2. How heart disease develops into heart failure
There are four major functional mechanisms through which cardiac disease can produce heart failure.
More than one mechanism can operate in the same cat.
Impaired ventricular filling
During diastole, the ventricles relax and fill with blood. When the ventricular wall becomes stiff, relaxation and filling become impaired.
This is particularly important in HCM. The thickened left ventricular wall reduces ventricular compliance, meaning the chamber requires greater pressure to accommodate incoming blood.
Restrictive cardiomyopathy produces a similar problem through myocardial or endocardial stiffness and fibrosis.
Reduced ventricular contraction
During systole, the ventricles contract to eject blood.
When myocardial contractility decreases substantially, the heart cannot pump enough blood to maintain normal circulation. Dilated cardiomyopathy is a classic example of this mechanism.
The ventricle may enlarge as it attempts to compensate for reduced pumping efficiency, but progressive dysfunction can eventually overwhelm this response.
Pressure overload
When the heart must pump against abnormally high pressure, the affected ventricular wall experiences increased mechanical stress.
Systemic hypertension, pulmonary hypertension, and obstruction of blood leaving the heart can contribute to pressure overload and ventricular wall thickening.
Volume overload
When excessive blood enters a ventricular chamber, the heart must accommodate and pump a greater volume.
Valve regurgitation, congenital shunts, and certain high-output conditions can produce this problem. Over time, the affected chamber can enlarge, and filling pressures can rise.
3. The step-by-step pathogenesis of pulmonary edema
THE CENTRAL MECHANISM OF LEFT-SIDED CONGESTIVE HEART FAILURE
1. Underlying myocardial disease
The heart muscle becomes thickened, stiff, damaged, or weakened.
1. Abnormal ventricular function
The left ventricle cannot fill or pump normally.
1. Increased left ventricular filling pressure
Pressure increases during ventricular filling.
1. Left atrial and pulmonary venous pressure increase
Pressure is transmitted backward into the pulmonary circulation.
1. Pulmonary capillary pressure increases
Fluid begins escaping from the pulmonary capillaries.
1. Pulmonary edema and respiratory distress
Fluid accumulates in lung tissue and air spaces, interfering with breathing.
Mechanism described in the Merck Veterinary Manual and ACVIM consensus statement.
Why does pressure increase in the lungs?
The pulmonary veins carry oxygenated blood from the lungs into the left atrium. Blood then passes through the mitral valve into the left ventricle.
When the left ventricle cannot accept blood normally, pressure increases in the left atrium. That pressure is transmitted backward through the pulmonary veins to the pulmonary capillaries.
As pulmonary capillary hydrostatic pressure rises, fluid moves out of the blood vessels and into the surrounding lung tissue. With worsening congestion, fluid enters the alveoli, the small air sacs responsible for gas exchange.
This accumulation is called cardiogenic pulmonary edema.
The fluid interferes with normal oxygen transfer, increasing respiratory effort and eventually causing significant breathing difficulty.
Why do some cats develop pleural effusion?
Pulmonary edema and pleural effusion are related complications, but they are not the same condition.
• Pulmonary edema: Fluid accumulates within the lung tissue and alveoli.
• Pleural effusion: Fluid accumulates in the pleural space between the lungs and the chest wall.
Cats with CHF can develop either condition or both. Pleural effusion is a particularly important manifestation of feline heart failure and can restrict normal lung expansion.
4. The role of compensatory mechanisms
The body initially attempts to preserve circulation when cardiac function deteriorates.
These compensatory mechanisms can maintain blood pressure and blood flow for a considerable period, but prolonged activation can contribute to worsening heart failure.
Two important systems are involved.
Sympathetic nervous system activation
When cardiac output falls, the sympathetic nervous system responds by:
• Increasing heart rate.
• Increasing myocardial contractility.
• Narrowing peripheral blood vessels through vasoconstriction.
These changes temporarily support blood pressure and circulation. However, sustained sympathetic activation increases cardiac workload.
Renin-angiotensin-aldosterone system activation
Reduced kidney perfusion stimulates renin release and activates the renin-angiotensin-aldosterone system (RAAS).
The resulting hormonal responses include:
1. Renin initiates the conversion of angiotensinogen into angiotensin I.
2. Angiotensin-converting enzyme converts angiotensin I into angiotensin II.
3. Angiotensin II promotes vasoconstriction and stimulates aldosterone release.
4. Aldosterone increases sodium and water retention by the kidneys.
5. Antidiuretic hormone also contributes to water retention.
The resulting increase in circulating blood volume raises venous return and cardiac preload. This can initially help maintain circulation, but it also increases the workload and filling pressures of an already compromised heart.
As congestion progresses, these mechanisms can contribute to additional fluid accumulation and worsening cardiac dysfunction.
5. What happens inside the heart muscle?
The pathogenesis of feline HCM involves more than simply an increase in ventricular wall thickness.
Histopathological changes described in affected feline hearts include:
• Myofiber disarray, in which the arrangement of heart muscle fibers becomes abnormal.
• Degeneration and loss of myocardial cells.
• Replacement fibrosis, in which lost myocardial tissue is replaced by collagen-rich connective tissue.
• Interstitial collagen deposition.
• Accumulation of inflammatory cells, particularly macrophages.
• Reduced capillary density and irregular arrangement of small blood vessels.
• Changes associated with myocardial vascular dysfunction.
These changes can compromise myocardial structure, tissue integrity, and normal cardiac function.
An important distinction is that individual cardiomyocyte enlargement has not been established as a consistent microscopic feature of feline HCM. The thickened ventricular wall can involve several remodeling processes rather than simply enlargement of individual muscle cells.
What does recent molecular research show?
A 2025 research article, Selected Pathway Analyses to Gain Mechanistic Insights into the Pathogenesis of Feline Hypertrophic Cardiomyopathy, investigated molecular changes in the left ventricular myocardium of cats with HCM.
The researchers examined tissue from 15 cats with confirmed HCM and 30 control cats. They assessed gene-expression markers associated with myocardial growth, hypertrophy, vascularization, and communication between cells.
The findings included:
• Increased expression of several markers associated with myocardial growth and remodeling.
• Changes in markers involved in vascularization.
• Increased expression of markers associated with interactions between cardiomyocytes and inflammatory cells.
• Higher expression of several investigated markers in affected male cats compared with affected females.
The researchers proposed that some of these changes could represent compensatory responses to myocardial injury and attempts to preserve cardiac function. They also identified possible roles for fibrosis, inflammatory signaling, and vascular remodeling.
However, the study does not establish a single molecular cause of feline HCM. Its findings are mechanistic evidence that requires further investigation, rather than proof that any one pathway initiates or determines the progression of CHF.
6. Why congestive heart failure can appear suddenly
Feline heart disease can progress without obvious outward symptoms.
A cat may have significant myocardial abnormalities while maintaining sufficient cardiac function to avoid clinical heart failure. The heart and the body's compensatory systems can preserve circulation until the disease becomes severe enough to overwhelm those mechanisms.
When compensation becomes inadequate:
• Left atrial pressure can rise substantially.
• Pulmonary capillary pressure can increase.
• Fluid can accumulate in the lungs or pleural space.
• Breathing becomes faster and more difficult.
• Reduced cardiac output can contribute to poor peripheral circulation.
An episode that appears sudden may therefore represent the clinical emergence of a chronic underlying disease.
Cats may initially show only subtle changes, such as reduced appetite, hiding, or increased resting respiratory rate. Labored breathing is a common presenting sign once CHF develops.
7. Other complications of feline cardiomyopathy
Congestive heart failure is not the only serious consequence of myocardial disease.
Arterial thromboembolism
Cats with cardiomyopathy, particularly those with substantial left atrial enlargement and impaired atrial function, are at risk of developing blood clots.
Abnormal blood flow within an enlarged left atrium can contribute to blood stasis and thrombus formation. A clot can subsequently travel into the arterial circulation and obstruct blood flow elsewhere in the body.
A particularly serious complication is a saddle thrombus, in which a clot obstructs blood flow near the division of the aorta supplying the hind limbs.
Possible signs include:
• Sudden hindlimb weakness or paralysis.
• Severe pain.
• Cold hindlimbs or paws.
• Difficulty walking or inability to stand.
Sudden hindlimb paralysis or severe weakness requires immediate emergency veterinary attention.
Arrhythmias
Structural myocardial abnormalities can interfere with normal electrical conduction.
Arrhythmias may contribute to weakness, collapse, fainting episodes, and other signs of inadequate circulation. Some cats with cardiomyopathy can also experience sudden cardiac death.
Reduced cardiac output
When the heart cannot maintain adequate forward blood flow, the delivery of oxygenated blood to peripheral tissues and organs can decrease.
In severe cases, affected cats may develop cold extremities, low body temperature, weakness, and reduced appetite.
8. How veterinarians diagnose and stage the disease
Diagnosis involves identifying both the underlying cardiac abnormality and the presence of congestive heart failure.
Diagnostic tests
• Test — Purpose
• Echocardiography — Evaluates heart structure, wall thickness, chamber dimensions, and cardiac function.
• Chest radiographs — Help identify pulmonary edema and other evidence of CHF.
• Electrocardiography (ECG) — Identifies abnormal heart rhythms.
• Blood pressure measurement — Helps identify systemic hypertension associated with ventricular thickening.
• Thyroid testing — Helps identify hyperthyroidism as a contributing condition.
• NT-proBNP testing — Provides additional information about myocardial stress and helps assess possible cardiac causes of respiratory distress.
• Cardiac troponin testing — Can provide evidence of myocardial injury and help distinguish cardiac from noncardiac respiratory distress.
Echocardiography is the gold-standard diagnostic test for feline cardiomyopathy. Chest radiographs are important for identifying cardiogenic pulmonary edema, although the radiographic appearance in cats can vary. Cardiac biomarkers are supportive tests and should not be interpreted in isolation.
ACVIM stages of feline cardiomyopathy
The American College of Veterinary Internal Medicine uses a staging system to describe disease progression and clinical risk.
• Stage — Description
• A — Cats predisposed to cardiomyopathy but without evidence of myocardial disease.
• B1 — Cardiomyopathy is present without clinical signs, with a lower risk of imminent CHF or arterial thromboembolism.
• B2 — Cardiomyopathy is present without clinical signs, but risk of CHF or arterial thromboembolism is higher.
• C — Cats that have developed clinical signs of CHF or arterial thromboembolism, even if those signs subsequently resolve with treatment.
• D — Cats with heart failure that is refractory to standard treatment.
Left atrial enlargement is an important indicator of increased risk of CHF and arterial thromboembolism. Other factors, including impaired left atrial function, arrhythmias, and reduced ventricular function, also contribute to risk assessment.
9. Treatment in relation to the disease mechanism
Treatment is directed at stabilizing the cat, reducing congestion, and managing the underlying cardiac abnormality.
For acute CHF:
• Oxygen supplementation helps support cats experiencing respiratory distress.
• Diuretics reduce excess fluid accumulation associated with pulmonary edema.
• Thoracocentesis may be necessary when pleural effusion is causing respiratory distress.
• Gentle handling and a quiet environment help minimize stress during stabilization.
Long-term management depends on the cardiomyopathy phenotype, severity of heart failure, cardiac function, and presence of complications.
Monitoring respiratory rate, body weight, kidney function, and electrolyte concentrations helps assess treatment response and identify complications associated with ongoing management.
Medication selection and adjustments must be made by the treating veterinarian. A cat experiencing respiratory distress needs emergency assessment rather than an attempted medication adjustment at home.
Frequently asked questions
1. What is the main cause of congestive heart failure in cats?
Cardiomyopathy is a major underlying cause, with hypertrophic cardiomyopathy being the most common feline cardiomyopathy phenotype. It causes abnormalities in ventricular structure and function that can increase pressure in the left atrium and pulmonary circulation, resulting in fluid accumulation.
2. Why does hypertrophic cardiomyopathy cause pulmonary edema?
The thickened left ventricular wall becomes less compliant and cannot relax and fill normally. Increased ventricular filling pressure is transmitted backward into the left atrium and pulmonary veins, raising pulmonary capillary pressure. Fluid then escapes from the capillaries into the lung tissue and alveoli.
3. Does every cat with cardiomyopathy develop congestive heart failure?
No. Many cats with cardiomyopathy remain without clinical signs, and some have a normal life expectancy. Others develop CHF, arterial thromboembolism, or sudden cardiac death. Disease severity, left atrial enlargement, cardiac function, and other risk factors influence progression.
4. Is congestive heart failure in cats always left-sided?
No. Left-sided CHF is an important and common presentation, but right-sided and biventricular heart failure can also occur. Right-sided failure produces increased systemic venous pressure and may cause fluid accumulation in the abdomen, chest cavity, liver, or limbs. Right-sided CHF is less common in cats.
5. Why do cats with heart failure sometimes have fluid around their lungs instead of inside them?
Fluid around the lungs is called pleural effusion, whereas fluid within lung tissue and air spaces is called pulmonary edema. Both can result from abnormal cardiac pressures. Pleural effusion is a common manifestation of feline CHF and can substantially restrict lung expansion.
6. Is coughing a common sign of congestive heart failure in cats?
Coughing is less common in cats with cardiogenic pulmonary edema than in dogs. Increased respiratory rate and labored breathing are more characteristic signs of feline CHF.
7. Why can a cat with heart disease suddenly develop breathing problems?
Compensatory mechanisms can maintain circulation despite progressive cardiac abnormalities. When these mechanisms become inadequate, pulmonary pressure can rise and fluid can accumulate relatively quickly. Subtle increases in respiratory rate may also go unnoticed until breathing becomes visibly difficult.
8. Which journal article is most useful for understanding the pathogenesis?
Two particularly useful publications are: - The 2020 ACVIM consensus statement, which provides the clinical framework for feline cardiomyopathy classification, disease progression, diagnosis, and management. - The 2025 study Selected Pathway Analyses to Gain Mechanistic Insights into the Pathogenesis of Feline Hypertrophic Cardiomyopathy, which investigates molecular and cellular changes associated with feline HCM.
Editorial standards
Who wrote this guide
Written by VetWayfinder Editorial Team.
Every factual statement is tied to a cited source listed below. Report an error through the corrections page.
Sources
Each source supports at least one factual statement in this guide.
